Hvivo (HVO) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Nov 2015 07:00 AM
RNS
Grant of Share Option & Total Voting Rights
02 Nov 2015 07:01 AM
RNS
Trading Update
02 Nov 2015 07:00 AM
RNS
hVIVO invests in PrEP Biopharm Limited
23 Oct 2015 07:00 AM
RNS
Contract for over EUR1m with French Biotech
19 Oct 2015 07:00 AM
RNS
Appointment of Director
19 Oct 2015 07:00 AM
RNS
Completion of the Acquisition of Kinesis Pharma BV
09 Oct 2015 11:38 AM
RNS
Result of General Meeting & Update on Acquisition
05 Oct 2015 02:00 PM
RNS
Directors' Dealings
24 Sep 2015 07:00 AM
RNS
Half Yearly Report
22 Sep 2015 07:01 AM
RNS
Half Yearly Report
22 Sep 2015 07:00 AM
RNS
Proposed acquisition & Placing
24 Aug 2015 02:00 PM
RNS
Appointment of Co-Broker
21 Aug 2015 07:00 AM
RNS
Notice of Results
13 Aug 2015 07:00 AM
RNS
Trading update
06 Jul 2015 07:00 AM
RNS
Directors' Dealings
30 Jun 2015 11:39 AM
RNS
Result of AGM
30 Jun 2015 07:00 AM
RNS
AGM Statement
25 Jun 2015 02:00 PM
RNS
Exercise of Share Options
15 Jun 2015 07:00 AM
RNS
Appointment of Chief Financial Officer
10 Jun 2015 03:46 PM
RNS
EUR 2m contract with leading European biotech
08 Jun 2015 04:35 PM
RNS
Price Monitoring Extension
04 Jun 2015 04:40 PM
RNS
Second Price Monitoring Extn
04 Jun 2015 04:35 PM
RNS
Price Monitoring Extension
29 May 2015 07:00 AM
RNS
Notification of Major Interest in Shares
28 May 2015 10:14 AM
RNS
Posting of Annual Report & Notice of AGM
26 May 2015 12:00 PM
RNS
Result of AGM
22 May 2015 07:00 AM
RNS
Final Results
20 May 2015 03:29 PM
RNS
Holding(s) in Company
20 May 2015 07:00 AM
RNS
New services from Innovenn
14 May 2015 07:00 AM
RNS
Director's Dealings
13 May 2015 07:00 AM
RNS
Exercise of Share Options
12 May 2015 07:01 AM
RNS
Directorate Change
08 May 2015 07:00 AM
RNS
Director's Dealings
30 Apr 2015 06:26 PM
RNS
Director's Dealings
24 Apr 2015 02:00 PM
RNS
2014 Annual Report and Financial Statements
21 Apr 2015 03:43 PM
RNS
Award of Share Options
16 Apr 2015 07:01 AM
RNS
2014 Audited Preliminary Results
16 Apr 2015 07:00 AM
RNS
Confirmation of Change of Name to hVIVO plc
13 Apr 2015 07:00 AM
RNS
Change of Name to hVIVO plc
08 Apr 2015 09:06 AM
RNS
Holding(s) in Company
08 Apr 2015 09:05 AM
RNS
Holding(s) in Company
08 Apr 2015 07:00 AM
RNS
Directors' Dealings
07 Apr 2015 02:39 PM
RNS
Holding(s) in Company
07 Apr 2015 11:17 AM
RNS
Holding(s) in Company
02 Apr 2015 02:00 PM
RNS
Investor teach-in
02 Apr 2015 07:00 AM
RNS
InnoVenn expands products and first sales in US
01 Apr 2015 12:14 PM
RNS
Result of General Meeting
30 Mar 2015 07:00 AM
RNS
Contracts for EUR4.1m with US Biotech client
13 Mar 2015 04:45 PM
RNS
Placing to raise £2 million
06 Mar 2015 07:00 AM
RNS
Change of Registered Office

hVIVO is a contract research organization that conducts human challenge clinical trials for respiratory and infectious disease vaccines and therapeutics:

hVIVO offers services such as challenge trials, assay development, field trial bio-logistics, cell based assays, molecular services, compound efficacy and VRM, and biomarker analysis.

Formerly known as Retroscreen, hVIVO was renamed in 2015 when it went public on the London Stock Exchange.

hVIVO has a portfolio of 11 human challenge models, with more models in development. Their portfolio includes models for influenza, respiratory syncytial virus, human rhinovirus, asthma, COPD, cough, malaria, COVID-19, and hMPV.

hVIVO share price launched at 33p in 2012.

UK 100

Latest directors dealings